By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ascendis Pharma A/S 

Tuborg Boulevard 12

Hellerup    DK-2900  Denmark
Phone: 45-36-94-44-86 Fax: 45-36-94-40-10


SEARCH JOBS



Segment
Start Up





Company News
Ascendis Showcases New Data On Rare Disease Product Pipeline At ENDO 2017 4/3/2017 6:59:58 AM
Ascendis Reports Full Year 2016 Financial Results 3/23/2017 9:08:15 AM
Ascendis Announces Year-End 2016 Financial Results Conference Call On March 22 3/10/2017 8:20:56 AM
Ascendis Announces Publication Of Comprehensive Results From Randomized, Active-Controlled Phase 2 Trial Of Once-Weekly Transcon Growth Hormone In Pediatric Patients 2/17/2017 6:30:30 AM
Ascendis Reports Third Quarter 2016 Financial Results 12/1/2016 11:02:07 AM
Ascendis To Report Third Quarter 2016 Financial Results And Host Conference Call On November 30 11/17/2016 10:15:26 AM
Ascendis Eyes $112 Million IPO to Fund the Development of Growth Hormone Drug 10/19/2016 6:01:09 AM
Ascendis Pharma A/S Announces Proposed Public Offering Of ADSs 10/18/2016 12:11:47 PM
Ascendis Pharma A/S Announces Webcast Of R&D Update 9/23/2016 7:51:36 AM
Ascendis Pharma A/S Announces Multiple Transcon Growth Hormone Presentations At The European Society Of Paediatric Endocrinology Annual Meeting 9/9/2016 9:28:59 AM
12345
//-->